Related Experiment Video
Updated: Jan 29, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Targeted OMA1 therapies for cancer
1712 North Inc., San Francisco, CA.
Abstract:
The mitochondrial inner membrane proteins OMA1 and OPA1 belong to the BAX/BAK1-dependent apoptotic signaling pathway, which can be regulated by tumor protein p53 and the prohibitins PHB and PHB2 in the context of neoplastic disease. For the most part these proteins have been studied separate from each other. Here, I argue that the OMA1 mechanism of action represents the missing link between p53 and cytochrome c release. The mitochondrial fusion protein OPA1 is cleaved by OMA1 in a stress-dependent manner generating S-OPA1. Excessive S-OPA1 can facilitate outer membrane permeabilization upon BAX/BAK1 activation through its membrane shaping properties. p53 helps outer membrane permeabilization in a 2-step process. First, cytosolic p53 activates BAX/BAK1 at the mitochondrial surface. Then, in a second step, p53 binds to prohibitin thereby releasing the restraint on OMA1. This activates OMA1, which cleaves OPA1 and promotes cytochrome c release. Clearly, OMA1 and OPA1 are not root causes for cancer. Yet many cancer cells rely on this pathway for survival, which can explain why loss of p53 function promotes tumor growth and confers resistance to chemotherapies.
Insights
The OMA1 protein links tumor protein p53 to the apoptotic pathway by cleaving OPA1, promoting cytochrome c release. This pathway is crucial for survival in many cancer cells, explaining why p53 loss aids tumor growth.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Biology
Background:
- Mitochondrial inner membrane proteins OMA1 and OPA1 are involved in apoptosis.
- Tumor protein p53 and prohibitins regulate this pathway in cancer.
- OMA1 and OPA1 have largely been studied independently.
Purpose of the Study:
- To propose OMA1 as the missing link between p53 and cytochrome c release.
- To elucidate the mechanism by which OMA1, OPA1, and p53 interact in apoptosis.
- To explain the role of this pathway in cancer cell survival and chemoresistance.
Main Methods:
- The study is primarily theoretical, proposing a mechanism based on existing literature.
- It integrates knowledge of protein interactions and apoptotic signaling pathways.
- Focuses on the functional consequences of OMA1-mediated OPA1 cleavage.
Main Results:
- OMA1 cleaves OPA1 into S-OPA1 in a stress-dependent manner.
- Excess S-OPA1 aids outer mitochondrial membrane permeabilization via BAX/BAK1 activation.
- p53 activates BAX/BAK1 and subsequently OMA1 by binding prohibitin, leading to OPA1 cleavage and cytochrome c release.
Conclusions:
- The OMA1-OPA1 axis, regulated by p53, is a key mediator of apoptosis.
- This pathway is essential for the survival of many cancer cells.
- Dysfunction in this pathway, particularly loss of p53, contributes to tumor progression and therapy resistance.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

